Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  HCA Healthcare, Inc.    HCA

HCA HEALTHCARE, INC.

(HCA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Former KKR dealmaker launches healthcare-focused buyout firm

08/17/2020 | 02:05am EST
FILE PHOTO: Trading information for KKR & Co is displayed on a screen on the floor of the NYSE in New York

Jim Momtazee, a former dealmaker at U.S. buyout firm KKR & Co Inc, has launched his own firm to pursue private equity deals in the healthcare sector.

Momtazee, who spent 21 years at KKR and led its Americas healthcare team for a decade, said in a statement he formed Patient Square Capital together with Maria Walker, a former partner at consulting firm KPMG.

The move comes as the outbreak of the novel coronavirus has strained some healthcare providers, while spurring growth in some sectors such as telemedicine and vaccine production.

Patient Square Capital plans to look for deals across the healthcare industry, including technology-enabled services, biopharmaceuticals, the pharmaceutical value chain, medical devices, diagnostics, providers, digital health and consumer health, the statement said.

"We're going to be broad-based in our focus on all aspects of healthcare, bringing depth of knowledge, scale, expertise, and long-term view to our investments," Momtazee told Reuters in an interview.

Prior to leaving KKR last year, Momtazee worked on some of the buyout firm's biggest healthcare deals, including the $33 billion take-private of U.S. hospital operator HCA Healthcare Inc, as well as the acquisition of contract research firm PRA International for $1.3 billion in 2013.

By Chibuike Oguh


Reuters 2020
All news about HCA HEALTHCARE, INC.
11/03HCA HEALTHCARE : Inc. to Present at November Healthcare Conferences
BU
10/30HCA HEALTHCARE : Latest Covid-19 Wave Worries Hospitals Even With New Treatments
DJ
10/29HCA HEALTHCARE : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND..
AQ
10/26HCA EXPECTS 4-5% OF TOTAL PATIENT AD : Conf call
RE
10/26HCA Healthcare expects to treat COVID-19 patients throughout 2021
RE
10/26HCA Healthcare expects to treat COVID-19 patients throughout 2021
RE
10/26TENET HEALTHCARE : Amid New Covid-19 Surge, Hospitals Balance Virus Care With Mo..
DJ
10/26HCA HEALTHCARE, INC. : Results of Operations and Financial Condition, Regulation..
AQ
10/26HCA HEALTHCARE : 3Q Profit, Revenue Rise
DJ
10/26HCA HEALTHCARE : HCA Healthcare Reports Third Quarter 2020 Results
BU
More news
Financials (USD)
Sales 2020 51 190 M - -
Net income 2020 3 729 M - -
Net Debt 2020 30 246 M - -
P/E ratio 2020 14,4x
Yield 2020 0,28%
Capitalization 51 788 M 51 788 M -
EV / Sales 2020 1,60x
EV / Sales 2021 1,51x
Nbr of Employees 245 000
Free-Float 78,3%
Chart HCA HEALTHCARE, INC.
Duration : Period :
HCA Healthcare, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HCA HEALTHCARE, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 154,23 $
Last Close Price 153,05 $
Spread / Highest target 16,3%
Spread / Average Target 0,77%
Spread / Lowest Target -11,8%
EPS Revisions
Managers
NameTitle
Samuel N. Hazen President, CEO, Chief Operating Officer & Director
Thomas Fearn Frist Chairman
William B. Rutherford CFO, Chief Accounting Officer & Executive VP
Jonathan B. Perlin Chief Medical Officer & President-Clinical Service
P. Martin Paslick Chief Information Officer & Senior Vice President
Sector and Competitors